EP3630158
METHODS OF USE OF SOLUBLE CD24 FOR TREATING IMMUNE RELATED ADVERSE EVENTS IN CANCER THERAPIES
:
EP einkaleyfi: Þýðing ekki lögð inn:
21.5.2018:
13.7.2022:
18806547.8
:
20.5.2038
:
METHODS OF USE OF SOLUBLE CD24 FOR TREATING IMMUNE RELATED ADVERSE EVENTS IN CANCER THERAPIES
21.5.2018
13.7.2022
:
Oncoimmune, Inc.:
9430 Key West Avenue Suite 113, Rockville, Maryland 20850, US
:
Children's National Medical Center:
111 Michigan Avenue N.W., Washington, DC 20010, US
:
LIU, Yang:
Washington District of Columbia 20002, US
:
ZHENG, Pan:
Washington District of Columbia 20002, US
:
DEVENPORT, Martin:
Gaithersburg Maryland 20878, US
:
LIU, Mingyue:
Baltimore, Maryland 21207, US
:
201762509498 P:
22.5.2017:
US
:
US2018033728:
21.5.2018
:
A61K 38/17, C07K 14/705